Nembutal, the commercial name for pentobarbital sodium, is a high-potency short-acting barbiturate that has been a cornerstone of clinical sedation and emergency medicine for nearly a century. While its use in routine insomnia treatment has largely been supplanted by modern benzodiazepines, its role in critical care, neurology, and end-of-life medicine remains irreplaceable. Understanding the nuances […]
Introduction Pentobarbital sodium—historically known by the trade name Nembutal—is a synthetic barbiturate that has played a significant role in 20th-century medicine, pharmacology, and veterinary practice. Once widely prescribed for sedation, seizure control, and anesthesia, its use in human medicine has declined sharply due to safety concerns, high overdose risk, and the availability of safer alternatives. […]